Welcome to KBC Securities

We believe banking is a craft, not an art or a science. As the integrated Equity House of KBC Group, we combine specialist expertise, skill and personal commitment to bring lasting value to our clients and people.

More about us


Our services

Collapse research area

Latest research

Benelux Morning Note19 jan 2017

Ahold Delhaize: Slightly better in the US UCB: CIMZIA Ph3 trial meets primary efficacy endpoint

Benelux Morning Note18 jan 2017

D'Ieteren: Auto CEO interview, positive Galapagos: Adding a Chief Medical Officer to the ExCom MDxHealth: Further expansion of the ConfirmMDx coverage Mithra: US patent for Estetrol as emergency contraceptive Telegraaf Me ...

Benelux Morning Note17 jan 2017

Beter Bed Holding: Preview 4Q trading update Solvay: Historical financials adjusted for scope change

SIPEF: Seeing the plantation for the trees16 jan 2017

Today we upgrade Sipef to Buy and raise our TP to € 68.5. As a well-managed pure-play palm producer we believe Sipef is ideally positioned to take advantage of rising palm oil prices. The buy-out of the minorities in Agro Muk ...

Benelux Morning Note16 jan 2017

Ahold Delhaize: Preview 4Q16 – How hard will deflation bite? Boskalis: LOI for € 480m Oman project Econocom: In line FY16 with better net debt and FY17 guidance GrandVision: Essilor buying Luxottica Lucas Bols: Nominates ...

Melexis: a competitive edge in autonomous cars16 jan 2017

De langetermijngroeiperspectieven voor Melexis zien er sterk uit. Melexis' innovatieve producten zijn perfect aangepast voor de slimme, veilige, duurzame en design auto's van de toekomst. Melexis heft bovendien een competitie ...

Benelux Morning Note13 jan 2017

Melexis: A competitive edge in autonomous cars Real Estate Investment & Services: Muted performance Brussels office market in 2017E Dynamic Top Pick List;: Adding Melexis to our Dynamic Top Pick List

Benelux Company Flash: NN GROUP: Life is better together12 jan 2017

NN GROUP: Life is better together Recommendation: BUY- Rating unchanged Current price: € 32.52 Target price: € 41.00 NN’s planned acquisition of DL could prove much more accretive than generally expected as the compa ...